These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34644578)

  • 1. Dengue virus is sensitive to inhibition prior to productive replication.
    Talemi SR; Bartenschlager M; Schmid B; Ruggieri A; Bartenschlager R; Höfer T
    Cell Rep; 2021 Oct; 37(2):109801. PubMed ID: 34644578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
    Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
    Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404.
    van Cleef KW; Overheul GJ; Thomassen MC; Marjakangas JM; van Rij RP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2554-7. PubMed ID: 26856827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
    Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Helicase A Is an Important Host Factor Involved in Dengue Virus Replication.
    Wang Y; Chen X; Xie J; Zhou S; Huang Y; Li YP; Li X; Liu C; He J; Zhang P
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
    Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
    Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of Dengue Virus Protein NS2A Revealed a Novel Domain Responsible for Virus-Induced Cytopathic Effect and Interactions between NS2A and NS2B Transmembrane Segments.
    Wu RH; Tsai MH; Tsai KN; Tian JN; Wu JS; Wu SY; Chern JH; Chen CH; Yueh A
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A; Songprakhon P; Panwong S; Jantakee K; Kaewkod T; Tragoolpua Y; Sawasdee N; Lee VS; Nimmanpipug P; Yenchitsomanus PT
    Molecules; 2021 May; 26(11):. PubMed ID: 34071102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dengue virus replication by mycophenolic acid and ribavirin.
    Takhampunya R; Ubol S; Houng HS; Cameron CE; Padmanabhan R
    J Gen Virol; 2006 Jul; 87(Pt 7):1947-1952. PubMed ID: 16760396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
    Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
    Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2'-O-Methylation Mutant.
    Schmid B; Rinas M; Ruggieri A; Acosta EG; Bartenschlager M; Reuter A; Fischl W; Harder N; Bergeest JP; Flossdorf M; Rohr K; Höfer T; Bartenschlager R
    PLoS Pathog; 2015 Dec; 11(12):e1005345. PubMed ID: 26720415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A.
    Nobori H; Toba S; Yoshida R; Hall WW; Orba Y; Sawa H; Sato A
    Antiviral Res; 2018 Jul; 155():60-66. PubMed ID: 29758236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication.
    Ferrari M; Zevini A; Palermo E; Muscolini M; Alexandridi M; Etna MP; Coccia EM; Fernandez-Sesma A; Coyne C; Zhang DD; Marques ETA; Olagnier D; Hiscott J
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
    Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
    Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Dengue Virus Type 2 (DENV-2) NS4B-Interacting Host Factor, SERP1, Reduces DENV-2 Production by Suppressing Viral RNA Replication.
    Tian JN; Yang CC; Chuang CK; Tsai MH; Wu RH; Chen CT; Yueh A
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31461934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
    Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
    Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.